Participate in the CREDENCE study on type 2 diabetes and kidney health (Melbourne) 10 December 2014 Do you have type 2 diabetes? Do you have problems with your kidneys? If the answer to both questions is Yes, you may be able to take part in a clinical research study. The CREDENCEtm Study is looking at an investigational (study) medication (taken as a daily capsule) that may help protect the kidneys in people with type 2 diabetes. They are looking for people who: Are 30 years of age or older Have a diagnosis of type 2 diabetes Have kidney problems related to their diabetes Are currently taking medicines to control their kidney problems? If you choose to take part in the CREDENCEtm Study, you will be looked after by an experienced study team who will carefully monitor your health and support your diabetes management. You will continue to take your current diabetes medications. For more information please contact: Nicky Robinson on 9496 2645 or Clinical [email protected] This study has been approved by the Austin Health Human Research Ethics Committee. HREC: 28431754DNE3001
Partners 1 June 2026 Does your CGM meet anzCGM standards? Advertisement When you live with diabetes, glucose readings influence everyday choices: from food and exercise to conversations with your healthcare... Continue Reading
Blog 1 June 2026 Rebuilding after the fall: Brett Findlay’s story of recovery and resilience聽 Brett Findlay had just started a new job when he learnt he had type 1 diabetes. He figured he could manage diabetes by keeping his blood glucose levels consistently low. Then, one fateful day, he had a severe hypo. In this raw episode of Life on the Level, Brett talks about hypo unawareness, rebuilding after trauma, and the enduring strength of family. Continue Reading
Blog 1 June 2026 Life on the level podcast: returning for season 2聽 Life on the Level podcast is back with season 2. Hosted by young Aussies Isabella Magee and Sebastian Harris, this season explores what it's really like to live with type 1 diabetes; the challenges, the wins, and all the messy bits in between. Continue Reading
